ANN ARBOR, MI - Ron Weiser does not often speak at University of Michigan Board of Regents meetings, other than announcing ...
The firm highlighted oral VK2735 as potentially the “best” oral incretin in development ... The company’s pipeline includes CRB-701, a next-generation antibody-drug conjugate that targets Nectin-4 on ...
Latest studies being presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition highlight ...